Cholesterol levels linked to abnormal plasma thiol concentrations and thiol/disulfide redox status in hyperlipidemic subjects

Free Radical Biology and Medicine

Volumn 35, Issue 10, 2003, Pages 1286-1292

  Kinscherf, Ralf ^a   Cafaltzis, Konstantinos ^a   Röder, Falk ^a   Hildebrandt, Wulf ^b   Edler, Lutz ^b   Deigner, Hans Peter ^c   Breitkreutz, Raoul ^b   Feussner, Giso ^d   Kreuzer, Jörg ^d   Werle, Egon ^e   Michel, Gerd ^f   Metz, Jürgen ^a   Dröge, Wulf ^b  

^a UNIVERSITY OF HEIDELBERG   (Germany)

^b GERMAN CANCER RESEARCH CENTER DKFZ   (Germany)

^c SIRS Lab Jena   (Germany)

^d Department of Internal Medicine I ^*  (Germany)

^e UNIVERSITY HOSPITAL HEIDELBERG   (Germany)

^f ABBOTT GMBH AND CO KG   (Germany)

Author keywords

Arteriosclerosis; Free radicals; Glutathione in atherosclerosis; Redox status as a risk factor; Risk factors in hyperlipidemia; Thiol level as a risk factor

Indexed keywords

ACETYLCYSTEINE; AMINO ACID; DISULFIDE; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; LOW DENSITY LIPOPROTEIN CHOLESTEROL; TAURINE; THIOL;

AMINO ACID BLOOD LEVEL; ANGIOCARDIOGRAPHY; ARTICLE; BLOOD LEVEL; CHOLESTEROL BLOOD LEVEL; CLINICAL ARTICLE; CONTROLLED STUDY; CORONARY ARTERY OBSTRUCTION; CORRELATION ANALYSIS; HUMAN; HYPERLIPIDEMIA; ISCHEMIC HEART DISEASE; MONONUCLEAR CELL; OXIDATION REDUCTION REACTION; PRIORITY JOURNAL; PROTEIN DEGRADATION; SYMPTOMATOLOGY;

EID: 10744226376     PISSN: 08915849     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.freeradbiomed.2003.07.001     Document Type: Article

References (26)

1. Korhonen T., Savolainen M.J., Koistinen M.J., Ikaheimo M., Linnaluoto M.K., Kervinen K., Kesaniemi Y.A. Association of lipoprotein cholesterol and triglycerides with the severity of coronary artery disease in men and women. Atherosclerosis. 127:1996;213-220.
2. Franceschini G., Werba J.P., Safa O., Gikalov I., Sirtori C.R. Dose-related increase of HDL-cholesterol levels after N-acetylcysteine in man. Pharmacol. Res. 2:1993;213-218.
3. Dröge W. Aging-related changes in the thiol/disulfide redox state implications for the use of thiol antioxidants . Exp. Gerontol. 37:2002;1333-1345.
4. Kinscherf R., Hack V., Fischbach T., Friedmann B., Weiss C., Edler L., Bärtsch P., Dröge W. Low plasma glutamine in combination with high glutamate levels indicate risk for loss of body cell mass in healthy individuals the effect of N-acetyl-cysteine . J. Mol. Med. 74:1996;393-400.
5. Hack V., Breitkreutz R., Kinscherf R., Röhrer H., Bärtsch P., Taut F., Benner A., Dröge W. The redox state as a correlate of senescence and wasting and as a target for therapeutic intervention. Blood. 92:1998;59-67.
6. Dröge W. Radicals in the physiological control of cell function. Physiol. Rev. 82:2002;1-49.
7. O'Brien R.C., Balazs N., Mercuri J. In vitro and in vivo antioxidant properties of gliclazide. J. Diabetes Complications. 14:2000;201-206.
8. Natella F., Ghiselli A., Guidi A., Ursini F., Scaccini C. Red wine mitigates the postprandial increase of LDL susceptibility to oxidation. Free Radic. Biol. Med. 30:2001;1036-1044.
9. McAnlis G.T., McEneny J., Pearce J., Young I.S. Absorption and antioxidant effects of quercetin from onions in man. Eur. J. Clin. Nutr. 53:1999;92-96.
10. Tietze F. Enzymatic method for quantitative determination of nanogram amounts of total and oxidized glutathione application to mammalian blood and other tissues . Anal. Biochem. 27:1969;502-522.
11. + T cells. FASEB J. 8:1994;448-451.
12. Peterson G.L. A simplification of the protein assay method of Lowry et al. Which is more generally applicable. Anal. Biochem. 83:1977;346-356.
13. Meister A. Selective modification of glutathione metabolism. Science. 220:1983;471-477.
14. Sato H., Tamba M., Ishii T., Bannai S. Cloning and expression of a plasma membrane cystine/glutamate exchange transporter composed of two distinct proteins. J. Biol. Chem. 274:1999;11455-11458.
15. Ruiz E., Siow R.C.M., Bartlett S.R., Jenner A.M., Sato H., Bannai S., Mann G.E. Vitamin C inhibits diethylmaleate-induced L-cystine transport in human vascular smooth muscle cells. Free Radic. Biol. Med. 34:2003;103-110.
16. Eck H.-P., Dröge W. Influence of the extracellular glutamate concentration on the intracellular cyst(e)ine concentration in macrophages and on the capacity to release cysteine. Biol. Chem. Hoppe-Seyler. 370:1989;109-113.
17. Rosenblat M., Aviram M. Macrophage glutathione content and glutathione peroxidase activity are inversely related to cell-mediated oxidation of LDL in vitro and in vivo studies . Free Radic. Biol. Med. 24:1998;305-317.
18. Boggs S.E., McCormick T.S., Lapetina E.G. Glutathione levels determine apoptosis in macrophages. Biochem. Biophys. Res. Commun. 247:1998;229-233.
19. Ghibelli L., Fanelli C., Rotilio G., Lafavia E., Copolla S., Colussi C., Civitareale P., Ciriolo M.R. Rescue of cells from apoptosis by inhibition of active GSH extrusion. FASEB J. 12:1998;479-486.
20. Kinscherf R., Claus R., Wagner M., Gehrke C., Kamencic H., Hou D., Chen M., Nauen O., Schmiedt W., Kovacs G., Pill J., Metz J., Deigner H.P. Apoptosis caused by oxidized-LDL is manganese superoxide dismutase and p53-dependent. FASEB J. 12:1998;461-467.
21. Andrews N.P., Prasad A., Quyyumi A.A. N-acetylcysteine improves coronary and peripheral vascular function. J. Am. Coll. Cardiol. 37:2001;117-123.
22. Vita J., Frei B., Holbrook M., Gokce N., Leaf C., Keaney J.F. Jr. L-2-oxothiazolidine-4-carboxylic acid reverses endothelial dysfunction in patients with coronary artery disease. J. Clin. Invest. 101:1998;1408-1414.
23. Rattan A.K., Arad Y. Temporal and kinetic determinants of the inhibition of LDL oxidation by N-acetylcysteine (NAC). Atherosclerosis. 138:1998;319-327.
24. Galis Z.S., Asanuma K., Godin D., Meng X. N-acetyl-cysteine decreases the matrix-degrading capacity of macrophage-derived foam cells new target for antioxidant therapy? Circulation. 97:1998;2445-2453.
25. De Mattia D., Bravi M.C., Laurenti O., Cassone-Faldetta M., Proietti A., De Luca O., Armiento A., Ferri C. Reduction of oxidative stress by oral N-acetyl-L-cysteine treatment decreases plasma soluble vascular cell adhesion molecule-1 concentration in non-obese, non-dyslipidaemic, normotensive patients with non-insulin-dependent diabetes. Diabetologia. 41:1998;1392-1396.
26. Mansoor M.A., Bergmark C., Svardal A.M., Lonning P.E., Ueland P.M. Redox status and protein binding of plasma homocysteine and other aminothiols in patients with early-onset peripheral vascular disease. Arterioscler. Thromb. Vasc. Biol. 15:1995;232-240.